Anticancer Metallotherapeutics in Preclinical Development

E-ISSN： 1875-533x|18|31|4738-4752

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.31, 2011-11, pp. : 4738-4752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs

By Schönthal Axel H Chen Thomas C Hofman Florence M Louie Stan G Petasis Nicos A

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 197-208

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Anticancer Activity of DNA-based Cleavage Molecules

By Dass Crispin

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 1, 2006-02 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G Reily Michael D Baker J David

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

Preclinical development of therapeutic biologics

By Baumann Andreas

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 289-297

Informa Healthcare

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite